LETTER OF MEDICINESindependent drug informationLogin for subscribers
Subscribers can log in with the user data of the website to get full functionality.
Therefore LETTER OF MEDICINES also appears without displaying advertising of medicinal products. This prevents that the pharmaceutical industry can take as advertiser and thus as funding agencies influence on the scientific content of the journal, as eg happens in other journals and other media.
We are dedicated to research results related to drug therapy quickly and critically commented our readers – physicians in clinics and practices, pharmacists and medical students – to convey. In addition, there is a special concern of the editors, to point out deficiencies in the pharmaceutical market, such as the vast number of drugs, the pricing, the often dubious advertising and the camouflage of marketing as factual information. Moreover, we see it as our task to in terms of a rational and rational drug therapy on the benefits and side effects of old and new drugs critical report.
LETTER OF MEDICINES is a member of the International Society of Drug Bulletins (ISDB), a worldwide association of independent drug bulletins.
Since January 2008, each issue of MEDICINAL MAIL is certified as a structured interactive training of the Medical Association for the awarding of CME credits.
D. von Herrath, W. D. Ludwig, W. Thimme
More information is available at the-arzneimittelbrief_de
See detail information and download apk file: goo.gl/qYVCUA